SCHEMBL3963528

SCHEMBL3963528

CC(C)(C)c1cc(NC(=O)C(C)(C)S(=O)(=O)c2cc(Cl)c(Cl)s2)no1.CC(C)(C)c1cc(NC(=O)C(C)(C)S(=O)(=O)c2ccc(F)cc2)no1

nearest known ligand 0.68

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 8/20 0.68
CNR1 P21554 5/20 0.68
MAPK14 Q16539 2/20 0.48
RAB9A P51151 3/20 0.46
NPC1 O15118 2/20 0.46
MAPT P10636 3/20 0.44
HTT P42858 3/20 0.44
KMT2A Q03164 3/20 0.44
MEN1 O00255 2/20 0.44
NPSR1 Q6W5P4 1/20 0.44
ATM Q13315 1/20 0.44
GAA P10253 1/20 0.43
KDM4E B2RXH2 1/20 0.42
POLB P06746 1/20 0.42
EGFR P00533 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
TDP1 Q9NUW8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1463812 0.90 CNR2 (0.65) CNR2CNR1MAPK14RAB9ANPC1
SCHEMBL766938 0.88 CNR2 (0.79) CNR2CNR1MAPK14RAB9ANPC1
SCHEMBL3962727 0.86 CNR2 (0.62) CNR2CNR1MAPK14RAB9ANPC1
SCHEMBL469406 0.81 CNR2 (1.00) CNR2CNR1MAPK14RAB9AMAPT
SCHEMBL1464681 0.80 CNR2 (0.79) CNR2CNR1MAPK14RAB9ANPC1
SCHEMBL1464430 0.79 CNR2 (0.67) CNR2CNR1MAPK14RAB9ANPC1
SCHEMBL1463751 0.78 CNR2 (0.80) CNR2CNR1MAPK14RAB9ANPC1
SCHEMBL1464776 0.78 CNR2 (0.84) CNR2CNR1MAPK14RAB9ANPC1
SCHEMBL1463539 0.78 CNR2 (0.80) CNR2CNR1MAPK14RAB9ANPC1
SCHEMBL1465703 0.78 CNR2 (0.80) CNR2CNR1MAPK14RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2081905-A2 SULFONYL COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR Boehringer Ingelheim International GmbH (DE) 2009-07-29 EP claimed
WO-2008014199-A2 SULFONYL COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2008-01-31 WO claimed